Intended for healthcare professionals


Diabetes may be independent risk factor for hyperkalaemia

BMJ 2003; 327 doi: (Published 02 October 2003) Cite this as: BMJ 2003;327:812
  1. Paul R Jarman (, consultant neurologist,
  2. Hugh M Mather, consultant in diabetes and endocrinology
  1. National Hospital for Neurology and Neurosurgery, London WC1N 3BG
  2. Ealing Hospital, Ealing, Middlesex UB1 3HW

    EDITOR—Wrenger et al reported severe hyperkalaemia in patients taking spironolactone in combination with angiotensin converting enzyme inhibitors or angiotensin-II antagonists.1 The strikingly high prevalence of diabetes in these patients (80%) is likely to be important.

    In a study of the prevalence of hyperkalaemia in an unselected diabetic outpatient population we found that hyperkalaemia was …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription